Relationship Between Cerebrovascular Reactivity and Depression in Patients With End-Stage Renal Disease

Shuying LI, Rui CHEN, Weiting TANG, Xiaojie MA, Huabin CAI, Yong YOU

Acta Academiae Medicinae Sinicae ›› 2024, Vol. 46 ›› Issue (3) : 348-353.

PDF(836 KB)
Home Journals Acta Academiae Medicinae Sinicae
Acta Academiae Medicinae Sinicae

Abbreviation (ISO4): Acta Academiae Medicinae Sinicae      Editor in chief: Xuetao CAO

About  /  Aim & scope  /  Editorial board  /  Indexed  /  Contact  / 
PDF(836 KB)
Acta Academiae Medicinae Sinicae ›› 2024, Vol. 46 ›› Issue (3) : 348-353. DOI: 10.3881/j.issn.1000-503X.15891
Original Articles

Relationship Between Cerebrovascular Reactivity and Depression in Patients With End-Stage Renal Disease

Author information +
History +

Abstract

Objective to investigate the relationship between cerebrovascular reactivity(CVR)and emotional disorders in the patients undergoing continuous hemodialysis for end-stage renal disease(ESRD).Methods the clinical data of the ESRD patients undergoing continuous hemodialysis were collected.anxiety and depression of the patients were assessed by the Hamilton anxiety scale(HAMA)and Beck depression inventory,respectively.the cerebral hemodynamic changes during the breath holding test were monitored by transcranial Doppler sonography,and the breath-holding index(BHI)was calculated.the BHI≥0.69 and BHI<0.69 indicate normal CVR and abnormal CVR,respectively.Binary Logistic regression was employed To analyze the factors affecting the depressive state of ESRD patients.Results the group with abnormal CVR exhibited higher total cholesterol level(P=0.010),low density lipoprotein level(P=0.006),and incidence of depression(P=0.012)than the group with normal CVR.Compared with the non-depression group,the depression group displayed prolonged disease course(P=0.039),reduced body mass index(P=0.048),elevated HAMA score(P=0.001),increased incidence of anxiety(P<0.001),decreased BHI(P=0.015),and increased incidence of abnormal CVR(P=0.012).Binary Logistic regression analysis indicated anxiety as a contributing factor(OR=22.915,95%CI=2.653-197.956,P=0.004)and abnormal CVR as a risk factor(OR=0.074,95%CI=0.008-0.730,P=0.026)for depression.Conclusion Impaired CVR could pose a risk for depression in the patients with ESRD。

Key words

end-stage renal disease / cerebrovascular reactivity / depression / anxiety / transcranial Doppler sonography

Cite this article

Download Citations
Shuying LI , Rui CHEN , Weiting TANG , et al . Relationship Between Cerebrovascular Reactivity and Depression in Patients With End-Stage Renal Disease[J]. Acta Academiae Medicinae Sinicae. 2024, 46(3): 348-353 https://doi.org/10.3881/j.issn.1000-503X.15891

References

[1]
Chilcot J, Wellsted D, Da Silva-Gane M, et al. Depression on dialysis[J]. Nephron Clin Pract, 2008, 108(4):c256-c264.DOI:10.1159/000124749.
[2]
杨超, 张路霞, 赵明辉. 《中国慢性肾脏病早期评价与管理指南》解读[J]. 中国实用内科杂志, 2023, 43(10):839-841,876.DOI:10.19538/j.nk2023100109.
[3]
Angermann S, Schier J, Baumann M, et al. Cognitive impairment is associated with mortality in hemodialysis patients[J]. J Alzheimers Dis, 2018, 66(4):1529-1537.DOI:10.3233/JAD-180767.
[4]
Al-Jabi SW. Global research trends and mapping knowledge structure of depression in dialysis patients[J]. World J Psychiatry, 2023, 13(8):593-606.DOI:10.5498/wjp.v13.i8.593.
[5]
Jeon YH, Lim JH, Jeon Y, et al. The impact of severe depression on the survival of older patients with end-stage kidney disease[J]. Kidney Res Clin Pract, 2023.DOI:10.23876/j.krcp.22.268.
[6]
Qawaqzeh DTA, Masa’deh R, Hamaideh SH, et al. Factors affecting the levels of anxiety and depression among patients with end-stage renal disease undergoing hemodialysis[J]. Int Urol Nephrol, 2023, 55(11):2887-2896.DOI:10.1007/s11255-023-03578-1.
[7]
Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary:mild cognitive impairment:report of the guideline development,dissemination,and implementation subcommittee of the American Academy of Neurology[J]. Neurology, 2018, 90(3):126-135.DOI:10.1212/WNL.0000000000004826.
[8]
Chaiviboontham S, Phinitkhajorndech N, Tiansaard J. Symptom clusters in patients with end-stage renal disease undergoing hemodialysis[J]. Int J Nephrol Renovasc Dis, 2020, 13:297-305.DOI:10.2147/IJNRD.S271619.
[9]
Sprick JD, Nocera JR, Hajjar I, et al. Cerebral blood flow regulation in end-stage kidney disease[J]. Am J Physiol Renal Physiol, 2020, 319(5):F782-F791.DOI:10.1152/ajprenal.00438.2020.
[10]
Slessarev M, Mahmoud O, Albakr R, et al. Hemodialysis patients have impaired cerebrovascular reactivity to CO2 compared to chronic kidney disease patients and healthy controls:a pilot study[J]. Kidney Int Rep, 2021, 6(7):1868-1877.DOI:10.1016/j.ekir.2021.04.005.
[11]
Wolfgram DF, Novotny J, Goodman MJ, et al. Risk factors for intradialytic decline in cerebral perfusion and impaired cerebral autoregulation in adults on hemodialysis[J]. Hemodial Int, 2022, 26(1):48-56.DOI:10.1111/hdi.12974.
[12]
Masson P, Webster AC, Hong M, et al. Chronic kidney disease and the risk of stroke:a systematic review and meta-analysis[J]. Nephrol Dial Transplant, 2015, 30(7):1162-1169.DOI:10.1093/ndt/gfv009.
[13]
Liu P, De Vis JB, Lu H. Cerebrovascular reactivity (CVR) MRI with CO2 challenge:a technical review[J]. Neuroimage, 2019, 187:104-115.DOI:10.1016/j.neuroimage.2018.03.047.
[14]
Barrett KM, Ackerman RH, Gahn G, et al. Basilar and middle cerebral artery reserve:a comparative study using transcranial Doppler and breath-holding techniques[J]. Stroke, 2001, 32(12):2793-2796.DOI:10.1161/hs1201.098640.
[15]
Liu M, He E, Fu X, et al. Cerebral blood flow self-regulation in depression[J]. J Affect Disord, 2022, 302:324-331.DOI:10.1016/j.jad.2022.01.057.
[16]
Findlay MD, Dawson J, Dickie DA, et al. Investigating the relationship between cerebral blood flow and cognitive function in hemodialysis patients[J]. J Am Soc Nephrol, 2019, 30(1):147-158.DOI:10.1681/ASN.2018050462.
[17]
Chen HJ, Wang YF, Qi R, et al. Altered amygdala resting-state functional connectivity in maintenance hemodialysis end-stage renal disease patients with depressive mood[J]. Mol Neurobiol, 2017, 54(3):2223-2233.DOI:10.1007/s12035-016-9811-8.
[18]
Kim SJ, Song SH, Kim JH, et al. Statistical parametric mapping analysis of the relationship between regional cerebral blood flow and symptom clusters of the depressive mood in patients with pre-dialytic chronic kidney disease[J]. Ann Nucl Med, 2008, 22(3):201-206.DOI:10.1007/s12149-007-0108-x.
[19]
Castello-Branco RC, Cerqueira-Silva T, Andrade AL, et al. Association between risk of obstructive sleep apnea and cerebrovascular reactivity in stroke patients[J]. J Am Heart Assoc, 2020, 9(6):e015313.DOI:10.1161/JAHA.119.015313.
[20]
Richerson WT, Schmit BD, Wolfgram DF. The relationship between cerebrovascular reactivity and cerebral oxygenation during hemodialysis[J]. J Am Soc Nephrol, 2022, 33(8):1602-1612.DOI:10.1681/ASN.2021101353.
[21]
Miglinas M, Cesniene U, Janusaite MM, et al. Cerebrovascular disease and cognition in chronic kidney disease patients[J]. Front Cardiovasc Med, 2020, 7:96.DOI:10.3389/fcvm.2020.00096.
[22]
Rodrigues SF, Almeida-Paula LD, Granger DN. Synergistic effects of high blood cholesterol and hypertension on leukocyte and platelet recruitment in the cerebral microcirculation[J]. Hypertension, 2014, 63(4):747-752.DOI:10.1161/HYPERTENSIONAHA.113.02627.
[23]
Ishikawa M, Stokes KY, Zhang JH, et al. Cerebral microvascular responses to hypercholesterolemia:roles of NADPH oxidase and P-selectin[J]. Circ Res, 2004, 94(2):239-244.DOI:10.1161/01.RES.0000111524.05779.60.
[24]
Malygin YV, Orlova AS, Malygin VL. Conceptualization of comorbid anxiety and depressive disorders and approaches to their managing[J]. Zh Nevrol Psikhiatr Im S S Korsakova, 2022, 122(6):48-54.DOI:10.17116/jnevro202212206148.
[25]
Zhang W, Fu W, Yan L, et al. Impaired dynamic cerebral autoregulation in young adults with mild depression[J]. Psychophysiology, 2022, 59(1):e13949.DOI:10.1111/psyp.13949.
[26]
Darling AM, Richey RE, Akins JD, et al. Cerebrovascular reactivity is blunted in young adults with major depressive disorder:the influence of current depressive symptomology[J]. J Affect Disord, 2021, 295:513-521.DOI:10.1016/j.jad.2021.08.061.
PDF(836 KB)

Accesses

Citation

Detail

Sections
Recommended

/